E Fund Management Co., Ltd. Inovio Pharmaceuticals, Inc. Transaction History

E Fund Management Co., Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$0.79 - $1.91 $5,051 - $12,212	-6,394 Reduced 4.71%	129,289 $106,000
Q4 2022 Feb 14, 2023	BUY	$1.41 - $2.5 $11,280 - $20,000	8,000 Added 6.27%	135,683 $212,000
Q3 2022 Nov 14, 2022	SELL	$1.66 - $2.79 $66,053 - $111,016	-39,791 Reduced 23.76%	127,683 $220,000
Q2 2022 Aug 15, 2022	BUY	$1.44 - $3.98 $121,201 - $334,988	84,168 Added 101.03%	167,474 $290,000
Q1 2022 May 12, 2022	BUY	$2.97 - $5.2 $162,565 - $284,627	54,736 Added 191.59%	83,306 $299,000
Q4 2021 Feb 11, 2022	BUY	$4.99 - $7.46 $34,371 - $51,384	6,888 Added 31.77%	28,570 $143,000
Q3 2021 Nov 12, 2021	BUY	$7.16 - $9.69 $60,695 - $82,142	8,477 Added 64.2%	21,682 $155,000
Q1 2021 May 12, 2021	BUY	$8.81 - $16.96 $116,336 - $223,956	13,205 New	13,205 $122,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $1.41B
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.